What's The Thesis On ProQR Now, After Promising Phase 1 Data? By: Benzinga via Benzinga September 26, 2017 at 11:41 AM EDT ProQR Therapeutics NV (NASDAQ: PRQR), a nano-cap pre-clinical stage bio pharmaceutical company engaged in the discovery and development ... Read More >> Related Stocks: Proqr Therapeutics